Deutsch English Français

Contact

EP0590747

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP0590747

EP0590747 - A beta1-6N-acetylglucosaminyltransferase and a method for cloning proteins having enzymatic activity [Right-click to bookmark this link]
Former [1994/14]	A novel-beta1- 6 N-acetylglucosaminyltransferase, its acceptor molecule, leukosialin, and a method for cloning proteins having enzymatic activity
	[1999/26]
Status	The application is deemed to be withdrawn Status updated on 25.07.2003 Database last updated on 15.07.2024
Most recent event Tooltip	25.07.2003	Application deemed to be withdrawn	published on 10.09.2003 [2003/37]
Applicant(s)	For all designated states LA JOLLA CANCER RESEARCH FOUNDATION 10901 North Torrey Pines Road La Jolla, CA 92037 / US
	[1994/14]
Inventor(s)	01 / Fukuda, Minoru 2818 Passy Avenue San Diego, California 92122 / US
	02 / Bierhuizen, Marti F. A. Schiedamseweg 225 NL-3119 JB Schiedam / NL
	[1995/45]
Former [1994/14]	01 / Fukuda, Minoru 2818 Passy Avenue San Diego, California 92122 / US
	02 / Bierhuizen, Marti F. A. Schiedamseweg 225 NL-3119 JB Schiedam / US
Representative(s)	Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB Beselerstrasse 4 22607 Hamburg / DE
	[N/P]
Former [1994/14]	UEXKÜLL & STOLBERG Patentanwälte Beselerstrasse 4 D-22607 Hamburg / DE
Application number, filing date	93250268.5	29.09.1993
	[1994/14]
Priority number, date	US19920955041	01.10.1992 Original published format: US 955041
	[1994/14]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP0590747
	Date:	06.04.1994
	Language:	EN
	[1994/14]
	Type:	A3 Search report
	No.:	EP0590747
	Date:	15.03.1995
	Language:	EN
	[1995/11]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	25.01.1995
Classification	IPC:	C12N15/54, C12N9/10, C12N15/12, C12N15/86, C12N15/64, C12N5/10	[1999/26]
	CPC:	C07K16/40 (EP,US); C07K14/705 (EP,US); C07K14/70596 (EP,US); C12N15/64 (EP,US); C12N9/1051 (EP,US)
	Former IPC [1994/14]	C12N15/54, C12N9/10, C12N15/12, C07K13/00, C12N15/86, C12N15/64, C12N5/10
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1994/14]
Title	German:	Beta-6-N-Acetylglukosaminyltransferase und Verfahren zur Klonierung enzymatisch-aktiven Proteinen	[1999/26]
	English:	A beta1-6N-acetylglucosaminyltransferase and a method for cloning proteins having enzymatic activity	[1999/26]
	French:	Bêta-6-N-acétylglusaminyltransférase et méthode pour le clonage de protéines avec activité enzymatique	[1999/26]
	Former [1994/14]	Beta-6-N-Acetylglukosaminyltransferase, das Akzeptor-Molekül, Leukosialin und Verfahren zur Klonierung enzymatisch-aktiven Proteinen
	Former [1994/14]	A novel-beta1- 6 N-acetylglucosaminyltransferase, its acceptor molecule, leukosialin, and a method for cloning proteins having enzymatic activity
	Former [1994/14]	Bêta-6-N-acetylglucosaminyltransferase, l'accepteur leukosialin et méthode pour le clonage de protéines avec activité enzymatique
Examination procedure	13.09.1995	Examination requested [1995/45]
	10.12.1996	Despatch of a communication from the examining division (Time limit: M04)
	07.04.1997	Reply to a communication from the examining division
	06.06.1997	Despatch of a communication from the examining division (Time limit: M06)
	12.12.1997	Reply to a communication from the examining division
	20.07.1998	Despatch of a communication from the examining division (Time limit: M06)
	14.01.1999	Reply to a communication from the examining division
	24.02.1999	Despatch of a communication from the examining division (Time limit: M04)
	20.04.1999	Reply to a communication from the examining division
	18.10.1999	Despatch of a communication from the examining division (Time limit: M06)
	18.04.2000	Reply to a communication from the examining division
	04.10.2000	Despatch of a communication from the examining division (Time limit: M06)
	09.02.2001	Reply to a communication from the examining division
	14.08.2001	Despatch of a communication from the examining division (Time limit: M04)
	20.12.2001	Reply to a communication from the examining division
	17.10.2002	Communication of intention to grant the patent
	28.02.2003	Application deemed to be withdrawn, date of legal effect [2003/37]
	08.04.2003	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2003/37]
Fees paid	Renewal fee
	08.09.1995	Renewal fee patent year 03
	12.09.1996	Renewal fee patent year 04
	10.09.1997	Renewal fee patent year 05
	09.09.1998	Renewal fee patent year 06
	13.09.1999	Renewal fee patent year 07
	13.09.2000	Renewal fee patent year 08
	12.09.2001	Renewal fee patent year 09
	12.09.2002	Renewal fee patent year 10
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[DX] - ADAM PALLANT ET AL., "Characterization of cDNAs encoding human leukosialin and localization of the lekosialin gene to chromosome 16", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., WASHINGTON US, (198902), vol. 86, no. 4, pages 1328 - 1332 [DX] 9-15 * abstract * * page 1329, column L, paragraph 3 - page 1330, column L, paragraph 4 * * page 1331, column R, paragraph 2 - page 1332, column L, paragraph 1 *
		[X] - SHINICHI KUDO ET AL., "A short, novel promoter sequence confers the expression of human leukosialin, amajor sialoglycoprotein on leukocytes", JOURNAL OF BIOLOGICAL CHEMISTRY, BALTIMORE, MD US, (19910505), vol. 266, no. 13, pages 8483 - 8489, XP002978098 [X] 9-15 * abstract * * page 8484, column R, paragraph 2 - page 8485, column L, paragraph 1; figure 2 *
		[X] - C. SIMON SHELLEY ET AL., "Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., WASHINGTON US, (198904), vol. 86, no. 8, doi:doi:10.1073/pnas.86.8.2819, pages 2819 - 2823, XP002052839 [X] 9-15 * abstract * * page 2820, column R, paragraph 3; figure 2 * * page 2822, column L, paragraph 4 - column R, paragraph 1 * DOI: http://dx.doi.org/10.1073/pnas.86.8.2819
		[X] - MICHAEL HEFFERNAN ET AL., "Polyoma and hamster papovavirus large T antigen-mediated replication of expression shuttle vectors in Chinese hamster ovary cells", NUCLEIC ACIDS RESEARCH., ARLINGTON, VIRGINIA US, (19910111), vol. 19, no. 1, pages 85 - 92, XP008070010 [X] 16-23 * page 85, column R, paragraph 2 - page 86, column L, paragraph 3 * * page 86, column R, paragraph 3 * * page 87, column L, paragraph L - column R, paragraph 1 * * page 90, column L, paragraph 2 - column R, paragraph 1 * * page 91, column L, paragraph L - column R, paragraph 2 *
		[PX] - MARTI F.A. BIERHUIZEN ET AL., "Expression cloning of a cDNA encoding UDP-GlcNAc:Gal-beta-1-3-GalNAc-R (GlcNAc to GalNAc) beta-1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigens", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., WASHINGTON US, (19921001), vol. 89, no. 19, doi:doi:10.1073/pnas.89.19.9326, pages 9326 - 9330, XP002961059 [PX] 1-8,16-25 * abstract * * page 9326, column R, paragraph 3 * * page 9327, column L, paragraph 4 - paragraph 5 * * page 9327, column R, paragraph 3 - page 9328, column R, paragraph 1; figure 3 * * page 9329, column L, paragraph 3 - column R, paragraph 1 * * page 9329, column R, paragraph 3 * DOI: http://dx.doi.org/10.1073/pnas.89.19.9326

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p